CHUNGCHEONGBUK-DO < invest Korea

Daegu-Gyeongbuk High-tech Medical Complex (Medivalley)

Overview

• Location: Sinseo-dong, Dong-gu, Daegu City
• Project Period: 2009 ~ 2038 (Construction or ndustrial complex 2009~2013)
• Gross Area: 1,026,000 ㎡ (Business and R&D zones 439,000 ㎡)
• Implementer: Korea Land and Housing Corporation (LH)
• Project Cost: KRW4.6 trillion

Site Conditions

• Target Sector: Manufacturing and R&D about pharmaceuticals and advanced medical devices
• Rent: KRW 2.85 million/3.3㎡
• Occupancy Rate
  (As of January, 2023)

  산업단지 분양실적을 나타내는 표

  Land Use Planning	Total Area (1,000 ㎡)	Number of Tenants	Occupied (1,000 ㎡)	For rent (1,000 ㎡)	Occupancy Rate (%)
  Business and R&D Zone	439	27 entities*	341	98	77.8

  ※ Additional tenants: 32 entities in Korea Mediventure Center located within Daegu-Gyeongbuk High-tech Medical Complex (lot for sale), 6 entities in Communication Center (lease), 5 entities in New Drug Development Center (lease), 7 entities in 3D Convergence Technology Center (lease)
• Access: Medivalley is connected with 8 express ways through Dongdaegu (East Daegu) IC, an entrance ramp to Gyeongbu Expressway
  It is 5 minutes’ walk from a station of Daegu Metro line 1
• Key Feature: The best place to live and work as it is located within Daegu innovation city
  The best national medical R&D cluster
  (Four core infrastructures that include those for drug development and cutting-edge medical devices, Korea Brain Research Institute)
  Regulatory special cases according to Special Act on the Designation and Support of High-tech Medical Complexes and Regulation-Free Special Zone on Smart Wellness

Major Tenant

• Corporation: DongSung Pharm., Lutroinc, Jamlim Pharm., Surgident, Korea Pharma
• Research Center: Daegu Gyeongbuk Medical Innovation Foundation (DGMIF), Advanced Clinical Trial Center, Korea Brain Research Institute, Laboratory Animal Resources Bank, Training Center for Medical Technology and Test, etc.
• Support Agency: Daegu Regional FDA

Target Institution